Aberdeen Group’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.75M Buy
70,100
+958
+1% +$27K ﹤0.01% 772
2025
Q4
$2.18M Buy
69,142
+20,023
+41% +$664K ﹤0.01% 771
2025
Q3
$1.75M Sell
49,119
-4,749
-9% -$217K ﹤0.01% 792
2025
Q2
$3.06M Buy
53,868
+9,870
+22% +$558K 0.01% 745
2025
Q1
$2.51M Sell
43,998
-26,279
-37% -$1.79M ﹤0.01% 744
2024
Q4
$5.69M Sell
70,277
-7,081
-9% -$605K 0.01% 626
2024
Q3
$6.24M Sell
77,358
-25,317
-25% -$1.8M 0.01% 615
2024
Q2
$6.27M Sell
102,675
-2,032
-2% -$121K 0.01% 592
2024
Q1
$5.17M Sell
104,707
-1,293
-1% -$61.5K 0.01% 663
2023
Q4
$4.44M Sell
106,000
-3,944
-4% -$134K 0.01% 691
2023
Q3
$3.61M Hold
109,944
0.01% 607
2023
Q2
$3.89M Hold
109,944
0.01% 614
2023
Q1
$3.12M Buy
109,944
+28,270
+35% +$997K 0.01% 657
2022
Q4
$3.39M Buy
+81,674
New +$3.51M 0.01% 627

Other funds holding PRCT